Investing Profile

Kostas Alevizopoulos

CEO
Partner at Ventac Partners
Photo of Kostas Alevizopoulos, Partner at Ventac Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Ventac Partners Network
13 CONNECTIONS
cb
$100K - $5.0M
$1.5M
Research Project Manager Swiss Inst. for Cancer Res. & Schering-Plough Res. InstitutePresent
Head of R & D Apotech CorporationPresent
Chief Scientific Officer PNG Gerolymatos SAPresent
Vice President & Board Member Hellenic Biotechnology ClusterPresent
Chief Scientific Advisor Gerolymatos International SAPresent
Scientific Advisor Foltene Laboratories SrlPresent
Strategic Advisor Exogenus TherapeuticsPresent
Chief Executive Officer Medexis SAPresent
Partner Ventac PartnersPresent
Chief Executive Officer APIM TherapeuticsPresent
Ethnikon kai Kapodistriakon Panepistimion Athinon Diploma in Biochemistry Biology
University of Lausanne - UNIL Ph.D. Molecular Biology
Sign in with Google →
Sign in with Google →